LianBio Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss
LianBio (LIANY) had Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss of $312.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss · last filed 2023-11-13
- 2023-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $312.00K.
- 2023-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $550.00K.
- 2023-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $417.00K.
- 2022-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $848.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss |
|---|---|
| 2023-09-30 | $312.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $550.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $417.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $848.00K 10-Q · filed 2023-11-13 |
| 2022-09-30 | $1.22M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.05M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $766.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $6.00K 10-K · filed 2023-03-28 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 |